(Q40537203)

21 September 2017

Cyclooxygenase-2-regulated vascular endothelial growth factor release in gastric fibroblasts (English)

1 reference

21 September 2017

0 references

Shuhei Miura

1

1 reference

21 September 2017

Atsushi Tatsuguchi

2

1 reference

21 September 2017

Ken Wada

3

1 reference

21 September 2017

Hiroki Takeyama

4

1 reference

21 September 2017

Yoko Shinji

5

1 reference

21 September 2017

Tetsuro Hiratsuka

6

1 reference

21 September 2017

Seiji Futagami

7

1 reference

21 September 2017

Kazumasa Miyake

8

1 reference

21 September 2017

Katya Gudis

9

1 reference

21 September 2017

Yuji Mizokami

10

1 reference

21 September 2017

Takeshi Matsuoka

11

1 reference

21 September 2017

Choitsu Sakamoto

12

1 reference

21 September 2017

1 August 2004

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

21 September 2017

1 reference

21 September 2017

287

1 reference

21 September 2017

2

1 reference

21 September 2017

G444-51

1 reference

Cyclooxygenase-2 and adenylate cyclase/protein kinase A signaling pathway enhances angiogenesis through induction of vascular endothelial growth factor in rat sponge implants

21 September 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Selective cyclooxygenase-2 blocker delays healing of esophageal ulcers in rats and inhibits ulceration-triggered c-Met/hepatocyte growth factor receptor induction and extracellular signal-regulated kinase 2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Nonsteroidal anti-inflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Molecular and biological properties of the vascular endothelial growth factor family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Prostaglandin protects isolated guinea pig chief cells against ethanol injury via an increase in diacylglycerol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Vascular endothelial growth factor is a secreted angiogenic mitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: Shifting the angiogenic balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

COX-2 inhibitors. A new class of antiangiogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Irritant-induced cyclooxygenase-2 is involved in the defense mechanism of the gastric mucosa in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Roles of COX-1 and COX-2 in gastrointestinal pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Hepatocyte growth factor as a key to modulate anti-ulcer action of prostaglandins in stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Hepatocyte growth factor is the most potent endogenous stimulant of rabbit gastric epithelial cell proliferation and migration in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Localisation of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori related gastritis and gastric ulcer tissues in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00537.2003

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00537.2003

1 reference

21 September 2017

1 reference